Login

Verisec's Freja Emerges as Top Choice for UK Public Sector Identity Management | Johan Henrikson , CEO & Co-founder at Verisec AB 00:10:00

Share On Facebook Share On Twitter

Johan Henrikson is the CEO & Co-founder at Verisec AB

Recent Videos

00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences
00:10:00
James Anderson: Guanajuato Silver Expands with $50M Bolanitos Deal, Building Mexico’s Fastest-Growing Silver Producer|James Anderson,CHAIRMAN & CEO,Guanajuato Silver Company Ltd
00:10:00
Highland Copper Company Targets 2026 Construction Decision as Fully Permitted Copperwood Project Gains U.S. Federal Financing Momentum|Barry O’Shea,CEO,Highland Copper

Suggestions

00:10:00
Advancing Risk-Informed Decision Making in Tailings Management
00:00:00
Katharine A. Price, M.D. Oncologist, Mayo Clinic
00:10:00
Kevin Mahn, CIO of Hennion & Walsh Asset Management, shares insights on market trends in a CNBC interview.
00:10:00
Don't more minorities launch VC backed companies|Rachel ten Brink,Founder and General Partner,Red Bike Capital
00:00:00
Amanika Kumar, M.D. Gynecologic Oncologist, Mayo Clinic / Obesity and Endometrial Cancer – Mayo Clinic
00:10:00
Copper Mark's ESG Initiatives and Responsible Copper Practices
00:10:00
Ryan Simpson: My Journey to Becoming a Financial Planner | Ryan Simpson - Associate Financial Planner of Syverson Strege
00:10:00
Global Architecture and Construction Needs Rethinking|Andrew Anagnost,President and CEO,Autodesk
00:10:00
Jun Waide on VENTENY’s Role in Advancing Indonesia's MSMEs and Workforce Well-being | Junichiro Waide, CEO, PT Venteny Fortuna International.
00:10:00
Key Strategies for Maximizing Your Tax Return: What You Might Be Missing | Michelle Smalenberger, CEO, Financial Design Studio.
00:10:00
Accelerating Drug Development Through Superior Innovative Solutions|Ronnie Morris, MD,Champions Oncology Inc
00:00:00
Investigate why photoreceptor cells die / Constance Cepko, Ph.D. HARVARD MEDICAL SCHOOL

© 2017 - Neuhu+